J? Hepatology: Analysis of the efficacy of bear deoxycholic acid (UDCA) in the treatment of primary bile-based bilebaritis.
Time of Update: 2020-09-22
concluded that the preventive use of UDCA after PBC liver transplantation was associated with a decrease in the risk of disease recurrence, liver graft damage and death.
J Clin Oncol: The effect of valproic acid and valic acid in the treatment of elderly patients with acute myeloid leukemia.
Time of Update: 2020-09-03
We conducted a randomized Phase II trial designed with a 2x2 factor to study the therapeutic effects of histone deacetylase inhibitors valproic acid and full trans-retinal acid (ATRA) on untreated elderly patients with acute myeloid leukemia (AML).
Water-based coating wastewater hazards and treatment methods you know.
Time of Update: 2020-08-18
the original title: water-based coating wastewater hazards and treatment methods You know in industrial sewage treatment projects in the production and coating process of water-based coatings may produce wastewater
"Guidelines for primary diagnosis and treatment of gout and hyperuric acid (2019)" was published! Guide sharing.
Time of Update: 2020-07-21
Medical pulse editor written, unauthorized do not reproduce. . Introduction: In recent years, hyperuric acidemia, gout has become a common chronic disease, the construction of graded diagnosis and treatment system has also prompted
The American Society of Rheumatology lists depresinatrol as a first-line treatment for uric acid.
Time of Update: 2020-07-18
, June 30, 2020 -- The American Rheumatology Society's Gout Management Guide (2020 Edition) was published online at the same time by Arthritis Rheumatol and Arthritis Care Res. The 2020 edition of the new ACR guidelines introduces 42
FDA approves first treatment drug for long-chain fatty acid oxidation metabolic disease - Dojolvi
Time of Update: 2020-07-13
Ultragenyx, a maker of rare disease drugs, has announced that its new drug Crysvita for metabolic disorders has been approved by the FDA for the treatment of long-chain fatty acid oxidation metabolic disease (LC-FAOD
Clin Rheumatol: Prognostic factors for early recurrence of gout in patients who started uric acid reduction treatment during acute gout attacks
Time of Update: 2020-07-13
The purpose of this study was to explore the prognostic factors associated with the recurrence of gout attacks in patients who started ULT during acute gout episodes during the first 3 months.
Gastroenterology: nucleic acid polymer REP 2139/REP2165, noofovir combined interferon to improve HBV treatment
Time of Update: 2020-07-12
Recently, researchers examined the safety and efficacy of NAPs REP 2139 or REP 2165 in combination with fomacryite noofovirest (TDF) and polyglycol interferon alpha-2a (pegIFN) to treat chronic HBV infections that were negative for hepatitis E e antigen.
Gastroenterology: Bile acid chelating agent IW-3718 assisted in the treatment of refractive gastroesophageal reflux disease
Time of Update: 2020-07-10
The average change in weekly reflux frequency scores from baseline checkto to week 8 was reduced by 17.5% compared to the placebo group.
Omega-3 fatty acids can be used in colon cancer treatment
Time of Update: 2020-07-07
In several colon cancer cell systems, omega-3 fatty acids combined with 5-fluorourea can increase its growth inhibition.
JCEM: Vitamin B12 and folic acid concentrations in newly developed type 2 diabetes patients and the effects of metformin treatment
Time of Update: 2020-06-25
The main outcome indicators of the study were holoTC (ELISA), cobalamin and folic acid (electrochemical luminescence), fasting (HOMA-B, HOMA-IR), intravenous glucose tolerance test (IVGTT), beta cell function and systemic insulin sensitivity detected in the hyperinsulinemia clamp test.
J hepatology: The long-term effects of preventive treatment of deoxycholic acid in bears on primary bile-derived bileductitis
Time of Update: 2020-06-22
conclusion: Preventive UDCA use after liver transplantation in PBC patients was associated with a recurrence of the disease and a reduced risk of death.
Voclosporin with mycophenolic acid and low-dose steroids in combination with the treatment of lupus nephritis key 3-phase bed trial struck positive results
Time of Update: 2020-06-07
The global study, involving 357 LN patients, showed that voclosporin achieved a renal response rate of 40.8 percent,compared with 22.5 percent (p0.00 ) in the control group.
FDA accepts listing application for oberic acid treatment for non-alcoholic fatty hepatitis
Time of Update: 2020-06-07
recently, Intercept announced The FDA ( has accepted a market ingressation application for the treatment of non-alcoholic fatty hepatitis (NASH) for liver fibrosis and has been qualified
Application for FDA priority review for RNAi treatment with high oxalic acid uric acid
Time of Update: 2020-06-06
December, Alnylam announced that the Phase III ILLUMINATE-A study of lumasiran's treatment of PH1 had reached the primary therapeutic end and all secondary endpoints.
Zeao pharmaceutical hydrochloric acid Jacktinib tablets approved clinical treatment of moderate and severe adhesion dermatitis
Time of Update: 2020-05-31
image source: Insight Database ( It's worth noting that Hengrui's new class 1 drug, SHR0302, is also a JAK inhibitor and is currently being used in phase 2 clinical recruitment for myopic dermatitis.
Can the only approved treatment of the premature ejaculation drug hydrochloric acid, Dapositin, save Tyneside?
Time of Update: 2020-05-30
According to Guangdong Tynekang Pharmaceuticals april 17 issued a notice that the subsidiary Shandong Huapu Kaisheng 4 generic drugs Dapositin n'amphibutinn was approved by the NMPA, the commodity name "Eitting", to this end, Tynekang successfully
Ann Rheum Dis: Comparing the long-term outcome of a randomized controlled trial of tamoxolphos with mycophenolic acid-induced treatment for lupus nephritis
Time of Update: 2020-05-29
ROC analysis showed that at the 18th month uPCr 0.75, eGFR 80mL/min predicted the highest value of kidney prognosis.
Biopharmaceutical wastewater treatment process achieves a new breakthrough: continuous inactivation equipment can double energy saving
Time of Update: 2020-04-13
Continuous inactivation treatment equipment to effectively solve the problem of energy consumption, much attention in recent years, China through the accumulation of months, the overall level of the biopharmaceutical industry to achieve a significant increase.
Paint common sense: paint wastewater treatment is very important, and wastewater treatment methods are widely distributed
Time of Update: 2020-04-03
Guangdong diatom mud agent suggests placing a basin of cold water in the air conditioning room, so that the diatom mud wall can breathe effectively.